Q4 2022 MEI Pharma Inc Earnings Call Transcript
Good afternoon, and welcome to the MEI Pharma 2022 Fiscal Year-End Conference Call. Please be advised that the call is being recorded at the company's request. At this time, I would like to turn the call over to David Walsey, MEI's Senior Vice President on Corporate Affairs. Please go ahead.
Thank you, and good afternoon, everyone, and thank you for joining us today. After the market closed today, we filed our Form 10-K for the fiscal year ended June 30, 2022, with the Securities and Exchange Commission and issued our financial results and corporate highlights press release, both of which are available on our website at www.meipharma.com.
On our call today, we will provide a summary of financials from the fiscal year ended June 30, 2022, and then review progress in our programs and business over the last year. We will then open the call to your questions.
Before we get started, I want to call your attention to the
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |